The US Agency for Healthcare Research and Quality (AHRQ) will fund a new project to develop four computer-based decision-tools that will help clinicians and patients answering questions like: When to use genetic tests? How to deal with the results? Or which treatment could be the best?
Fighting breast cancer is always a race against time - early detection of breast carcinoma an essential condition for cure. Now Scientists from Finland, Germany and France developed a promising new CT technique with high resolution and contrast that visualises tumours that are even diffusely growing or those in dense breasts.
“Molecular breast imaging” (MBI), a new scintigraphy method developed by US researchers, might improve early detection of breast cancer in women with dense breasts. The results of an initial clinical study were recently presented at the Breast Cancer Symposium of the American Society of Clinical Oncology (ASCO) in Washington, DC, USA.
Tumour cells can migrate, sometimes also during a surgery to remove the tumour. US researchers recently found, that perioperative treatment with a drug known as colchicine might protect against recurrences at the site of the surgical wound.
More than 4,500 cancer and radiotherapy specialists will gather in Göteborg, Sweden, this September for the 27th annual congress of ESTRO. ESTRO 27 is to be held between the 14th and 18th September 2008 at the Göteborg Convention Centre in Göteborg.
Women who survive breast cancer for at least five years have a 89% chance that it will not recure. But those, who are still suffering and on endocrine treatment are likely to get arthralgia and arthritis.
More than 250,000 women under the age of forty are living with the disease in the US and 11,000 will be diagnosed in the next year. Even so, young women are underrepresented in many research studies and treatments, according to genomic expert Simon Chin.
The idea of measuring tissue stiffness using ultrasound is nothing new. But lately the field sets a rapid pace. “Real-time, hand-held elastography is now a commercial reality,” asserts Jonathan Ophir from the University of Texas Medical School.
Researchers compared the Norwegian organised population based mammogram screening every second year and a physician- or self-referrals annual test in the US. Both are equally sensitive, but the recall rate for abnormal results was lower in Norway.
It sounds impressively simple: An over-the-counter pain-relieving gel from the drugstore may reduce the uncomfortable and even dolorous feeling women experience during mammography exams, according to the a study published in the online edition of Radiology.
As rocks keep the secrets of the earth, bones might keep those of the body. A new study that will be publish in the September 1, 2008 issue of CANCER suggests, that factors responsible for higher bone mineral density might also lead to higher risk of breast cancer.
The HER2 gene causes a very aggressive kind of breast cancer. It influences the number of cancer stem cells and therefore as well the spreading of metastases. The University of Michigan Comprehensive Cancer Center now made the discovery that the drug Herceptin can drastically reduce the amount of the stem cell population in HER2 positive-breast cancer.
Since decades women carefully feel their breast. Hoping that they will not find any evidence for lumps or other changes, that might signal breast cancer. However, a review of recent studies conclude that self-exams do not appear to reduce deaths. Whereas radiation therapy may lower recurrence rate of rare breast cancer.
While in Europe experts still discuss whether mammography screening is the ideal tool to save women from breast cancer, the Wall Street Journal investigated if mammography is really enough. Physicians claim that women with higher risk to develop breast carcinoma should receive MRI or ultrasound.
Siemens Healthcare Diagnostics will showcase the combined strengths of Diagnostics Products Corporation (DPC), Bayer HealthCare Diagnostics and Dade Behring.
"Hearing the sad news that breast cancer has returned can be a devastating experience for patients, especially as this means that the disease is no longer curable. Doctors also find imparting this information to women with whom they have developed a trusting relationship over the years extremely distressing. However, optimal use of available treatments will enable more women to stay cancer-free…
Fujifilm Medical Systems USA, based in Stamford, Connecticut, reports that it's CR for mammography (FCRm), a full-field digital mammography system, is now available for use in mobile mammography environments.
The next big development in biological targeted therapies for advanced breast cancer will be drugs acting via multiple mechanisms, experts told delegates attending the 1st Asian Breast Cancer conference, held in New Delhi 9-10 February.
Artiste is a linear accelerator and CT scanner combined. At the German Cancer Research Centre, a team of scientists led by Professors Wolfgang Schlegel and Uwe Oelfke of the Medical Physics in Radiation Oncology division, contributed substantially to the technical development of the Artiste platform. They report that users will be able to observe and correct the actual position, extension and…
The prosecution of two doctors and a faith healer has been ordered by the Dutch appeal court, due to their treatment of a patient who died seven years ago.
'How do you treat the HIV-positive, diabetic, schizophrenic patient presenting with chest pain? By making the necessary information available for personalised medicine'
Sectra's wide portfolio on show at the ECR this year includes a new PACS workstation, a photon-counting MicroDose Mammography system, pre-operative solutions for orthopaedic surgery and the company's full range of Enterprise Control solutions.
For individualised radiotherapy, high-precision delineation and characterisation of the tumour is critical. If highest radiation doses are delivered in a targeted fashion, the chance of tumour cell kill increases and tumour control probability is enhanced.
Breast cancer morbidity has been the leading oncology disease (21.8%) in Russia since 1996 - and since 1981 in St. Petersburg. In Moscow, the morbidity has increased 52.4% in last 14 years.
A promising mammography screening technology By Andrew Smith PhD, principal scientist at Hologic, Inc. in Bedford, Mass, is involved in research and development of digital imaging systems.